Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging clinical uses for GM-CSF.

× No keyword cloud information.

6 in total

Review 1. Current issues in cancer. Biological therapy.

Authors: T Perren; P Selby
Journal: BMJ Date: 1992-06-20

2. Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor.

Authors: A Riccardi; M Danova; A Paccagnella; M Giordano; A Favaretto; M Panozzo; C Ghiotto; S Comis; M Fiorentino; L Chieco-Bianchi
Journal: Ann Hematol Date: 1993-04 Impact factor: 3.673

3. Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer.

Authors: K Eguchi; J Kabe; S Kudo; K Mano; H Morinari; K Nakada; K Noda; Y Saito; T Tanaka; T Uzawa
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

4. Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.

Authors: C Bokemeyer; H J Schmoll; B Metzner; J Beyer; H J Illiger; M Kneba; H Ostermann; B Kynast; U Räth; H Poliwoda
Journal: Ann Hematol Date: 1993-08 Impact factor: 3.673

Review 5. The side-effect profile of GM-CSF.

Authors: A C Stern; T C Jones
Journal: Infection Date: 1992 Impact factor: 3.553

6. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.

Authors: A G Stewart; T Cotterill; T Harris
Journal: Immunology Date: 1994-05 Impact factor: 7.397

6 in total